Pharmaco - Press Releases

Date	Title	Company
22-Sep-2020	Global Controlled Release Drug Delivery Technology Systems Market Size Sales To Reach US$ 75 Billion By 2026	Kuick Research
22-Sep-2020	Medicxi announces the closing of its first €200 million Secondary Fund, led by Pantheon with co-lead LGT Capital Partners	Medicxi
21-Sep-2020	Ampersand Capital Partners Acquires American Laboratory Products Company	Ampersand Capital Partners
21-Sep-2020	Lonza Announces Scientific Advisory Board to Further Strengthen Drug Discovery Solutions & Services	Lonza Group AG
21-Sep-2020	Oramed Pharmaceuticals to Present at the European Association for the Study of Diabetes (EASD) Annual Meeting	Oramed Pharmaceuticals Inc.
21-Sep-2020	Late-breaking ESMO Presentation Shows Libtayo® (cemiplimab) Monotherapy Increases Overall Survival in First-line Advanced Non-small Cell Lung Cancer with PD-L1 Expression of >=50%	Regeneron Pharmaceuticals, Inc.
21-Sep-2020	Immune Regulation Limited Raises £40.6 Million / $53.4 Million Series B Equity Financing	B3C newswire
21-Sep-2020	MagForce AG Publishes Shareholder Letter	MagForce AG
21-Sep-2020	Global Point-of-Care Testing (POCT) Devices Market\| Top Key players: Abbott, Alere, Roche, Siemens, Abaxis, and Acon Laboratories	Lexis Business Insights
21-Sep-2020	Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners	Relief Therapeutics Holdings AG
21-Sep-2020	Global Monoclonal Mouse Antibody Market\| Top Key players: Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals, and Seattle Genetics	Lexis Business Insights
21-Sep-2020	Hyde Engineering + Consulting Announces New VP of Global Engineering	Hyde Engineering + Consulting, Inc.
21-Sep-2020	Hyde Engineering + Consulting Announces New VP of Global Engineering	Hyde Engineering + Consulting, Inc.
21-Sep-2020	Innovent and Lilly Jointly Release Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with GEMZAR® (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020	Innovent Biologics, Inc.
20-Sep-2020	Verzenio® Significantly Reduced the Risk of Cancer Recurrence by 25% for People with HR+, HER2- High Risk Early Breast Cancer	Eli Lilly and Company
20-Sep-2020	Janssen Presents Findings from Global, Multi-Center Trial Examining Amivantamab in Combination with Lazertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer	The Janssen Pharmaceutical Companies of Johnson & Johnson
20-Sep-2020	Blueprint Medicines Reports ARROW Trial Data at ESMO Virtual Congress 2020 Demonstrating Durable Clinical Benefits of GAVRETO(TM) (Pralsetinib) in Patients with Advanced RET-Mutant Medullary Thyroid Cancer	Blueprint Medicines Corporation
19-Sep-2020	Preparation products of Yiling Pharma approved by FDA for launch in the US market	Shijiazhuang Yiling Pharmaceutical Co, Ltd.
18-Sep-2020	Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Arena Pharmaceuticals, Inc.
18-Sep-2020	UAE Pharmaceutical Life Science Market Drug Medicine Retail Pharmacy Sales Unit Price Cost Database Report 2020	Kuick Research